Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,035,382
-
Share change
-
+78,186
-
Total reported value
-
$17,207,590
-
Price per share
-
$5.67
-
Number of holders
-
19
-
Value change
-
+$334,577
-
Number of buys
-
9
-
Number of sells
-
9
Institutional Holders of EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) as of Q4 2014
As of 31 Dec 2014,
EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,035,382 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, Cormorant Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, GEODE CAPITAL MANAGEMENT, LLC, Spark Investment Management LLC, GOLDMAN SACHS GROUP INC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.